TSS
EVGN icon

Two Sigma Securities’s Evogene EVGN Stock Holding History

Two Sigma Securities’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,465
Closed -$9.6K – 1921
2026
Q1 		$9.6K Buy
+12,465
New +$11.8K ﹤0.01% 1468
2025
Q4 		– Sell
-11,406
Closed -$13K – 1629
2025
Q3 		$13K Sell
11,406
-9,683
-46% -$12.3K ﹤0.01% 1186
2025
Q2 		$27K Buy
21,089
+7,527
+56% +$9.21K ﹤0.01% 1168
2025
Q1 		$17K Buy
13,562
+2,403
+22% +$3.62K ﹤0.01% 1133
2024
Q4 		$20.9K Buy
+11,159
New +$22K ﹤0.01% 1309
2024
Q3 		– Sell
-1,315
Closed -$8.55K – 3074
2024
Q2 		$8.55K Buy
+1,315
New +$9.18K ﹤0.01% 2824
2024
Q1 		– Sell
-1,237
Closed -$10.4K – 3130
2023
Q4 		$10.4K Sell
1,237
-232
-16% -$1.46K ﹤0.01% 2812
2023
Q3 		$8.62K Buy
1,469
+373
+34% +$3.27K ﹤0.01% 2718
2023
Q2 		$11.7K Buy
+1,096
New +$7.41K ﹤0.01% 2574
2022
Q3 		– Sell
-1,025
Closed -$8K – 2738
2022
Q2 		$8K Buy
+1,025
New +$10K ﹤0.01% 2074

Other funds holding EVGN

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Two Sigma Securities's EVGN Position: Q2 2026 in Review

Two Sigma Securities sold out of Evogene (EVGN) in Q2 2026, closing a stake of 12,465 shares — an estimated $9.6K sold.

Two Sigma Securities first reported a position in EVGN in Q2 2022 and held it in 10 quarters. The position peaked at $27K in Q2 2025. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

  • Two Sigma Securities reported no remaining Evogene position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 12,465 Evogene shares in Q2 2026, an estimated $9.6K.
  • Two Sigma Securities first reported a position in Evogene in Q2 2022 and held it in 10 quarters.
  • Two Sigma Securities's Evogene position peaked at $27K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.